Advertisement
Advertisement

TMDX

TMDX logo

TransMedics Group, Inc. Common Stock

74.29
USD
Sponsored
+0.82
+1.12%
Jul 21, 15:59 UTC -4
Closed
exchange

After-Market

74.25

-0.04
-0.05%

TMDX Earnings Reports

Positive Surprise Ratio

TMDX beat 18 of 29 last estimates.

62%

Next Report

Date of Next Report
Jul 30, 2026
Estimate for Q2 26 (Revenue/ EPS)
$187.03M
/
$0.47
Implied change from Q1 26 (Revenue/ EPS)
+7.53%
/
+56.67%
Implied change from Q2 25 (Revenue/ EPS)
+18.85%
/
-48.91%

TransMedics Group, Inc. Common Stock earnings per share and revenue

On May 05, 2026, TMDX reported earnings of 0.30 USD per share (EPS) for Q1 26, missing the estimate of 0.62 USD, resulting in a -52.00% surprise. Revenue reached 173.93 million, compared to an expected 176.09 million, with a -1.22% difference. The market reacted with a -23.19% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 0.47 USD, with revenue projected to reach 187.03 million USD, implying an increase of 56.67% EPS, and increase of 7.53% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Intuitive Surgical Inc.
Report Date
Jul 16, 2026 For Q2 26
Estimate
$2.55
Actual
$2.80
Surprise
+9.79%
logo
AngioDynamics, Inc.
Report Date
Jul 14, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+23.75%
FAQ
For Q1 2026, TransMedics Group, Inc. Common Stock reported EPS of $0.30, missing estimates by -52%, and revenue of $173.93M, -1.22% below expectations.
The stock price moved down -23.19%, changed from $94.93 before the earnings release to $72.92 the day after.
The next earning report is scheduled for Jul 30, 2026.
Based on 12 analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.47 and revenue of $187.03M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement